Doxycycline better than azithromycin for treating Chlamydia trachomatis infection in MSM

Chlamydia trachomatis infection is the most commonly reported sexually transmitted infection (STI) in the United States, with approximately 2.8 million infections reported annually.
A new study by Dr Mary B. Keegan, MD and team reported that Azithromycin and doxycycline are both recommended treatments for rectal Chlamydia trachomatis (CT) infection however doxycycline was significantly more effective than a single dose of azithromycin for the treatment of rectal CT in men who have sex with men (MSM).
This study is published in Clinical Infectious Diseases.
The objective of the study was to determine whether Azithromycin and doxycycline, which is a better drug to treat Chlamydia trachomatis infection.
The study was a randomized, double-blinded, placebo-controlled trial compared azithromycin (single 1-g dose) versus doxycycline (100 mg twice daily for 7 days) for the treatment of rectal CT in men who have sex with men (MSM) in Seattle and Boston. Participants were enrolled after a diagnosis of rectal CT in clinical care and underwent repeated collection of rectal swabs for nucleic acid amplification testing (NAAT) at study enrollment and 2 weeks and 4 weeks post enrollment. The primary outcome was microbiologic cure (CT-negative NAAT) at 4 weeks. The complete case (CC) population included participants with a CT-positive NAAT at enrollment and a follow-up NAAT result; the intention-to-treat (ITT) population included all randomized participants.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.